Leuthold Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-51,658
Closed -$4.64M 195
2022
Q2
$4.64M Sell
51,658
-1,286
-2% -$130K 0.66% 51
2022
Q1
$5.87M Buy
+52,944
New +$5.59M 0.75% 46
2020
Q3
Sell
-30,234
Closed -$2.77M 178
2020
Q2
$2.77M Buy
+30,234
New +$2.9M 0.41% 87

Other funds holding MDT

Leuthold Group's MDT Position: Q3 2022 in Review

Leuthold Group sold out of Medtronic (MDT) in Q3 2022, closing a stake of 51,658 shares — an estimated $4.64M sold.

Leuthold Group first reported a position in MDT in Q2 2020 and held it in 3 quarters. The position peaked at $5.87M in Q1 2022. 1,931 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • Leuthold Group reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
  • Leuthold Group sold 51,658 Medtronic shares in Q3 2022, an estimated $4.64M.
  • Leuthold Group first reported a position in Medtronic in Q2 2020 and held it in 3 quarters.
  • Leuthold Group's Medtronic position peaked at $5.87M in Q1 2022.
  • 1,931 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Leuthold Group's 13F filing for Q3 2022, filed 31 Oct 2022.